Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Morris

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The New England Journal of Medicine|June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative ColitisGeert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
American Journal of Health Behavior|October 14, 2017
Clinic Appointment Attendance in Adults with Serious Mental Illness and DiabetesDouglas D Gunzler, Nathan Morris, Jarrod E Dalton, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Temperature (Austin, Tex.)|February 8, 2021
COVID-19 and thermoregulation-related problems: Practical recommendationsHein Daanen, Stephan Bose-O'Reilly, Matt Brearley, et al.
Oncotarget|October 6, 2015
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survivalStephen P Fink, Lois L Myeroff, Revital Kariv, et al.
Hospital Pediatrics|January 7, 2018
Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma RepositorySteven L Shein, Obada Farhan, Nathan Morris, et al.
Lancet (London, England)|November 24, 2024
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through studyMarc Ferrante, Geert D'Haens, Vipul Jairath, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The New England Journal of Medicine|June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative ColitisGeert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
American Journal of Health Behavior|October 14, 2017
Clinic Appointment Attendance in Adults with Serious Mental Illness and DiabetesDouglas D Gunzler, Nathan Morris, Jarrod E Dalton, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Temperature (Austin, Tex.)|February 8, 2021
COVID-19 and thermoregulation-related problems: Practical recommendationsHein Daanen, Stephan Bose-O'Reilly, Matt Brearley, et al.
Oncotarget|October 6, 2015
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survivalStephen P Fink, Lois L Myeroff, Revital Kariv, et al.
Hospital Pediatrics|January 7, 2018
Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma RepositorySteven L Shein, Obada Farhan, Nathan Morris, et al.
Lancet (London, England)|November 24, 2024
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through studyMarc Ferrante, Geert D'Haens, Vipul Jairath, et al.
Pageof 6